A quagmire of European patent laws creates challenges for generic pharmaceutical companies

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:50 / 51
页数:2
相关论文
共 50 条
  • [41] Patent protection in the laws of Iran and the emphasis of European Union on the TRIPS agreement
    Sasani, Rababe Rostam
    REVISTA BRASILEIRA DE DIREITO, 2023, 19 (01):
  • [42] Incompletion of the European common market: The problem of extending pharmaceutical patent protection
    Raciti, EP
    INNOVATION AND THE INTELLECTUAL PROPERTY SYSTEM, 1996, : 145 - 169
  • [43] Impact of European Pharmaceutical Price Regulation on Generic Price CompetitionA Review
    Jaume Puig-Junoy
    PharmacoEconomics, 2010, 28 : 649 - 663
  • [44] Impact of European Pharmaceutical Price Regulation on Generic Price Competition A Review
    Puig-Junoy, Jaume
    PHARMACOECONOMICS, 2010, 28 (08) : 649 - 663
  • [45] Settlements between brand and generic pharmaceutical companies: A reasonable antitrust analysis of reverse payments
    Yvon, Anne-Marie C.
    FORDHAM LAW REVIEW, 2006, 75 (03) : 1883 - 1912
  • [46] The patent system: Current and future policy challenges - A view from the European patent office
    Desantes, M
    PATENTS, INNOVATION AND ECONOMIC PERFORMANCE, 2004, : 309 - 313
  • [47] From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies
    Hashemi-Meshkini, Amir
    Varmaghani, Mehdi
    Yousefi, Mehdi
    Yaghoubifard, Saeed
    Zekri, Hedieh-Sadat
    Nikfar, Shekoufeh
    Kebriaeezadeh, Abbas
    JOURNAL OF RESEARCH IN PHARMACY PRACTICE, 2014, 3 (03) : 88 - 93
  • [48] Legal challenge to India's patent laws threatens access to generic drugs, says charity
    Moszynski, Peter
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
  • [49] Measles and rubella in the World Health Organization European Region:: Diversity creates challenges
    Spika, JS
    Wassilak, S
    Pebody, R
    Lipskaya, G
    Deshevoi, S
    Güris, D
    Emiroglu, N
    JOURNAL OF INFECTIOUS DISEASES, 2003, 187 : S191 - S197
  • [50] Branded or Generic, the Legal Analysis and Strategic Management of Pharmaceutical Patent Disputes-The Taiwan Model
    Su, Chia-Jui
    NTUT JOURNAL OF INTELLECTUAL PROPERTY LAW AND MANAGEMENT, 2014, 3 (02): : 102 - 117